一般医生和医学学生对非药物干预治疗痴呆症的现有知识和态度
Lou L Frankenstein1,2, Lea Pickard1, Philipp Franikowski3
1Department of Psychology, Chemnitz University of Technology, Chemnitz, Germany.
Frontiers in medicine
|August 7, 2025
概括
德国的全科医生没有充分利用非药物治疗痴呆症的干预措施. 加强他们的教育和解决资源不确定性,可以提高痴呆症患者的治疗质量.
科学领域:
- 老年学是一门学科.
- 痴呆症护理 痴呆症护理 痴呆症护理
- 一般的做法一般的做法
背景情况:
- 德国的全科医生很少为痴呆症患者开有效的非药物干预措施.
- 本研究调查了全科医生的教育,知识,经验和对非药物干预的态度,以确定改善痴呆症护理质量的策略.
研究的目的:
- 评估德国全科医生对痴呆症护理的非药物干预教育和实践的现状.
- 确定影响全科医生对痴呆症患者处方非药物干预措施的障碍和促进因素.
主要方法:
- 对医学学生 (N=115) 和从业人员 (N=19) 进行了关于痴呆症护理教育和非药物干预 (职业治疗,行为治疗) 的在线调查.
- 实践者 (N=41) 也评价了他们对非药物治疗与痴呆症药物治疗的使用和评估.
- 与全科医生的半结构面试 (N=12) 探索了影响处方决定的上下文因素,信仰,知识和态度.
主要成果:
- 在医学教育中,非药物干预措施的代表性不足,尽管有潜在的副作用,但药物治疗往往是首选的.
- 一般医生对行为和职业治疗表现出异质的态度,在预算法规和对痴呆症患者的资源分配方面存在普遍的不确定性.
- 在全科医生中,对为痴呆症患者分配资源的保留是明显的.
结论:
- 提高痴呆症护理的质量需要更好地告知全科医生关于非药物干预措施的好处和可访问性.
- 解决教育差距和与资源相关的不确定性对于增加对痴呆症有效的非药物治疗方法的采用至关重要.
相关概念视频
Dementia
165
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
165
Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262
Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
206
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
206
Assessment of the Gastrointestinal System II: Health Perception Pattern
162
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
162
Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669


